Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis.

Albay CEQ, Leyson FGD, Cheng FC

Open source

DOI
10.1186/s12883-020-01808-y
Published
2020 Jun 3
Container
BMC neurology
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12883-020-01808-y,
  title = {Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis.},
  author = {Albay CEQ and Leyson FGD and Cheng FC},
  year = {2020},
  journal = {BMC neurology},
  doi = {10.1186/s12883-020-01808-y},
  url = {https://doi.org/10.1186/s12883-020-01808-y}
}

RIS

TY  - JOUR
TI  - Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis.
AU  - Albay CEQ
AU  - Leyson FGD
AU  - Cheng FC
PY  - 2020
JO  - BMC neurology
DO  - 10.1186/s12883-020-01808-y
UR  - https://doi.org/10.1186/s12883-020-01808-y
ER  - 

APA

CEQ, A., FGD, L., & FC, C. (2020). Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis.. BMC neurology. https://doi.org/10.1186/s12883-020-01808-y

Source records